{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:21Z","timestamp":1793212041690,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,21]],"date-time":"2024-07-21T00:00:00Z","timestamp":1721520000000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["L30 DK126220"],"award-info":[{"award-number":["L30 DK126220"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.cgh.2022.07.008","type":"journal-article","created":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T12:07:39Z","timestamp":1658318859000},"page":"2222-2238","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6037-2883","authenticated-orcid":false,"given":"John","family":"Gubatan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant E.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole Haagen","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten Bogh","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael L.","family":"Eisenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Streett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2022.07.008_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cgh.2016.10.039","article-title":"Incidence and prevalence of Crohn\u2019s disease and ulcerative colitis in Olmsted County, Minnesota from 1970 through 2010","volume":"15","author":"Shivashankar","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib2","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.cgh.2020.09.021","article-title":"Biologics for inflammatory bowel disease and their safety in pregnancy: a systematic review and meta-analysis","volume":"20","author":"Nielsen","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib3","doi-asserted-by":"crossref","first-page":"243","DOI":"10.14309\/ajg.0000000000000910","article-title":"Biologics during pregnancy in women with inflammatory bowel disease and risk of infantile infections: a systematic review and meta-analysis","volume":"116","author":"Gubatan","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.07.008_bib4","doi-asserted-by":"crossref","first-page":"285","DOI":"10.5534\/wjmh.190007","article-title":"Sexual dysfunction and fertility problems in men with inflammatory bowel disease","volume":"38","author":"Park","year":"2020","journal-title":"World J Mens Health"},{"key":"10.1016\/j.cgh.2022.07.008_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/gut.22.6.445","article-title":"Sulphasalazine and male infertility: reversibility and possible mechanism","volume":"22","author":"Toovey","year":"1981","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.07.008_bib6","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/19396368.2014.952391","article-title":"Inflammatory bowel disease in subfertile men and the effect of mesalazine on fertility","volume":"60","author":"Shin","year":"2014","journal-title":"Syst Biol Reprod Med"},{"key":"10.1016\/j.cgh.2022.07.008_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1136\/pgmj.62.726.269","article-title":"Male fertility in Crohn\u2019s disease","volume":"62","author":"Burnell","year":"1986","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cgh.2022.07.008_bib8","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3109\/01485017908985067","article-title":"Methotrexate and fertility in men","volume":"3","author":"El-Beheiry","year":"1979","journal-title":"Arch Androl"},{"key":"10.1016\/j.cgh.2022.07.008_bib9","first-page":"294","article-title":"Male fertility in cyclosporine-treated renal transplant patients","volume":"145","author":"Haberman","year":"1991","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.cgh.2022.07.008_bib10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.cgh.2022.07.008_bib11","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Int Med"},{"key":"10.1016\/j.cgh.2022.07.008_bib12","first-page":"1","article-title":"The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","volume":"2","author":"Peterson","year":"2011"},{"key":"10.1016\/j.cgh.2022.07.008_bib13","unstructured":"Higgins JP, Green S, eds. Cochrane handbook for systematic reviews of interventions (Vol. 4). John Wiley & Sons;\u00a02011."},{"key":"10.1016\/j.cgh.2022.07.008_bib14","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/01.MIB.0000164023.10848.c4","article-title":"Infliximab and semen quality in men with inflammatory bowel disease","volume":"11","author":"Mahadevan","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2022.07.008_bib15","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1097\/MIB.0000000000001081","article-title":"Evaluation of the quality of semen and sexual function in men with inflammatory bowel disease","volume":"23","author":"Valer","year":"2017","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2022.07.008_bib16","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/ecco-jcc\/jjy198","article-title":"Semen quality and sperm DNA integrity in patients with severe active inflammatory bowel disease and effects of tumour necrosis factor-alpha inhibitors","volume":"13","author":"Grosen","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2022.07.008_bib17","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1053\/j.gastro.2019.02.041","article-title":"Vedolizumab does not impair sperm DNA integrity in men with inflammatory bowel disease","volume":"156","author":"Grosen","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.07.008_bib18","article-title":"Pretty baby: successful use of anti-TNF-\u03b1 therapy for Crohn\u2019s disease in pregnancy","author":"Dunne","year":"2011","journal-title":"European Crohns and Colitis Organisation"},{"key":"10.1016\/j.cgh.2022.07.008_bib19","doi-asserted-by":"crossref","first-page":"2270","DOI":"10.3899\/jrheum.140189","article-title":"Pregnancy outcomes in subjects exposed to certolizumab pegol","volume":"42","author":"Clowse","year":"2015","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib20","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1038\/ajg.2016.405","article-title":"Birth outcomes in children fathered by men treated with anti-TNF-\u03b1 agents before conception","volume":"111","author":"Larsen","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.07.008_bib21","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1111\/apt.13960","article-title":"Vedolizumab exposure in pregnancy: outcomes from clinical studies in inflammatory bowel disease","volume":"45","author":"Mahadevan","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.cgh.2022.07.008_bib22","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1038\/s41395-018-0202-9","article-title":"Pregnancy outcomes reported during the 13-year TREAT registry: a descriptive report","volume":"113","author":"Lichtenstein","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.07.008_bib23","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.cgh.2018.04.001","article-title":"Paternal disease activity is associated with difficulty in conception among men with inflammatory bowel diseases","volume":"17","author":"Ananthakrishnan","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ecco-jcc\/jjz137","article-title":"The safety profile of vedolizumab in ulcerative colitis and Crohn\u2019s disease: 4 years of global post-marketing data","volume":"14","author":"Cohen","year":"2020","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2022.07.008_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1053\/j.gastro.2021.03.020","article-title":"Paternal exposure to immunosuppressive and\/or biologic agents and birth outcomes in patients with immune-mediated inflammatory diseases","volume":"161","author":"Meserve","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.07.008_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/ibd\/izac028","article-title":"Normal sperm DNA integrity in patients with inflammatory bowel disease on ustekinumab maintenance therapy","author":"Grosen","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2022.07.008_bib26","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1053\/gast.2001.28692","article-title":"Azathioprine treatment and male fertility in inflammatory bowel disease","volume":"121","author":"Dejaco","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.07.008_bib27","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjy086","article-title":"Sperm DNA integrity is unaffected by thiopurine treatment in men with inflammatory bowel disease","volume":"13","author":"Grosen","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.cgh.2022.07.008_bib28","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1111\/j.1572-0241.2000.01846.x","article-title":"Outcome of pregnancies when fathers are treated with 6-mercaptopurine for inflammatory bowel disease","volume":"95","author":"Rajapakse","year":"2000","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.07.008_bib29","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/gast.2003.50014","article-title":"The safety of 6-mercaptopurine for childbearing patients with inflammatory bowel disease: a retrospective cohort study","volume":"124","author":"Francella","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.07.008_bib30","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1038\/ajg.2010.138","article-title":"Outcomes of pregnancies fathered by inflammatory bowel disease patients exposed to thiopurines","volume":"105","author":"Teruel","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2022.07.008_bib31","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/gutjnl-2016-312123","article-title":"Reassuring results on birth outcomes in children fathered by men treated with azathioprine\/6-mercaptopurine within 3 months before conception: a nationwide cohort study","volume":"66","author":"N\u00f8rg\u00e5rd","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.cgh.2022.07.008_bib32","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.reprotox.2017.08.013","article-title":"Paternal use of azathioprine\/6-mercaptopurine or methotrexate within 3 months before conception and long-term health outcomes in the offspring: a nationwide cohort study","volume":"73","author":"Friedman","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.cgh.2022.07.008_bib34","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ibd\/izab205","article-title":"Low-dose methotrexate therapy does not affect semen parameters and sperm DNA.","volume":"28","author":"Grosen","year":"2022","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2022.07.008_bib35","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1053\/j.gastro.2018.02.025","article-title":"Methotrexate reduces DNA integrity in sperm from men with inflammatory bowel disease","volume":"154","author":"Ley","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2022.07.008_bib36","doi-asserted-by":"crossref","first-page":"628","DOI":"10.3899\/jrheum.100600","article-title":"Paternal exposure to methotrexate and pregnancy outcomes","volume":"38","author":"Beghin","year":"2011","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1093\/rheumatology\/ket390","article-title":"No evidence for an increased risk of adverse pregnancy outcome after paternal low-dose methotrexate: an observational cohort study","volume":"53","author":"Weber-Schoendorfer","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.cgh.2022.07.008_bib38","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.reprotox.2017.10.004","article-title":"Birth outcomes after preconception paternal exposure to methotrexate: a nationwide cohort study","volume":"74","author":"Winter","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.cgh.2022.07.008_bib39","first-page":"145","article-title":"Semen quality and human fertility: a prospective study with healthy couples","volume":"21","author":"Zinaman","year":"2000","journal-title":"J\u00a0Androl"},{"key":"10.1016\/j.cgh.2022.07.008_bib40","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/S0140-6736(97)10514-1","article-title":"Relation between semen quality and fertility: a population-based study of 430 first-pregnancy planners","volume":"352","author":"Giwercman","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2022.07.008_bib41","doi-asserted-by":"crossref","first-page":"l869","DOI":"10.1136\/bmj.l869","article-title":"Role of maternal age and pregnancy history in risk of miscarriage: prospective register-based study","volume":"364","author":"Magnus","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.cgh.2022.07.008_bib42","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1016\/S0140-6736(12)60820-4","article-title":"National, regional, and worldwide estimates of preterm birth rates in the year 2010 with time trends since 1990 for selected countries: a systematic analysis and implications","volume":"379","author":"Blencowe","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.cgh.2022.07.008_bib43","first-page":"387","article-title":"Congenital Disorders Expert Group. Estimating the birth prevalence and pregnancy outcomes of congenital malformations worldwide","volume":"9","author":"Moorthie","year":"2018","journal-title":"J\u00a0Community Genet"},{"key":"10.1016\/j.cgh.2022.07.008_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.2174\/1871530319666190313112110","article-title":"Inflammatory bowel disease therapies adversely affect fertility in men- a systematic review and meta-analysis","volume":"19","author":"Banerjee","year":"2019","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.cgh.2022.07.008_bib45","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibd.22948","article-title":"Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease","volume":"19","author":"Akbari","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/j.cgh.2022.07.008_bib46","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1530\/eje.0.1510629","article-title":"Tumor necrosis factor-alpha (TNF-alpha) promotes cell survival during spermatogenesis, and this effect can be blocked by infliximab, a TNF-alpha antagonist","volume":"151","author":"Suominen","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.cgh.2022.07.008_bib47","article-title":"Characterization of the role of tumor necrosis factor apoptosis inducing ligand (TRAIL) in spermatogenesis through the evaluation of trail gene-deficient mice","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cgh.2022.07.008_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0165-1110(93)90015-F","article-title":"The genetic toxicology of 6-mercaptopurine","volume":"296","author":"Mosesso","year":"1993","journal-title":"Mutat Res"},{"key":"10.1016\/j.cgh.2022.07.008_bib49","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s00383-012-3197-0","article-title":"Methotrexate induces germ cell apoptosis and impairs spermatogenesis in a rat","volume":"29","author":"Sukhotnik","year":"2013","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.cgh.2022.07.008_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/art.38368","article-title":"Pregnancy outcome after methotrexate treatment for rheumatic disease prior to or during early pregnancy: a prospective multicenter cohort study","volume":"66","author":"Weber-Schoendorfer","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.cgh.2022.07.008_bib51","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/AOG.0000000000001936","article-title":"Risk of adverse pregnancy outcome after paternal exposure to methotrexate within 90 days before pregnancy","volume":"129","author":"Eck","year":"2017","journal-title":"Obstet Gynecol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522006759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356522006759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:43:55Z","timestamp":1761543835000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356522006759"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":51,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S1542356522006759"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2022.07.008","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paternal Medications in Inflammatory Bowel Disease and Male Fertility and Reproductive Outcomes: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2022.07.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the AGA Institute","name":"copyright","label":"Copyright"}]}}